F. vom Dorp

2.5k total citations
86 papers, 1.9k citations indexed

About

F. vom Dorp is a scholar working on Surgery, Molecular Biology and Urology. According to data from OpenAlex, F. vom Dorp has authored 86 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Surgery, 25 papers in Molecular Biology and 19 papers in Urology. Recurrent topics in F. vom Dorp's work include Bladder and Urothelial Cancer Treatments (43 papers), Urinary and Genital Oncology Studies (28 papers) and Urological Disorders and Treatments (16 papers). F. vom Dorp is often cited by papers focused on Bladder and Urothelial Cancer Treatments (43 papers), Urinary and Genital Oncology Studies (28 papers) and Urological Disorders and Treatments (16 papers). F. vom Dorp collaborates with scholars based in Germany, Hungary and Austria. F. vom Dorp's co-authors include H. Rübben, Tibor Szarvas, Karl H. Jakobs, Martina Schmidt, Paschal A. Oude Weernink, Sandrine Evellin, Jon W. Lomasney, Holger Rehmann, Süleyman Ergün and Henning Reis and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

F. vom Dorp

78 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
F. vom Dorp Germany 24 1.0k 564 376 324 237 86 1.9k
Udayan Guha United States 24 1.0k 1.0× 234 0.4× 679 1.8× 227 0.7× 471 2.0× 51 2.1k
Todd A. Swanson United States 18 1.6k 1.6× 238 0.4× 504 1.3× 236 0.7× 116 0.5× 39 2.4k
Karl X. Chai United States 24 796 0.8× 162 0.3× 270 0.7× 278 0.9× 218 0.9× 48 1.6k
Jürgen Serth Germany 26 1.1k 1.0× 343 0.6× 337 0.9× 400 1.2× 552 2.3× 69 1.7k
Miguel Á. Japón Spain 27 1.1k 1.1× 227 0.4× 360 1.0× 283 0.9× 162 0.7× 63 2.4k
Andrea Kolbus Austria 26 1.4k 1.4× 167 0.3× 476 1.3× 283 0.9× 85 0.4× 39 2.5k
Takashi Shimano Japan 24 1.5k 1.5× 456 0.8× 854 2.3× 312 1.0× 341 1.4× 108 2.9k
Lynn Vitale‐Cross United States 16 824 0.8× 161 0.3× 537 1.4× 276 0.9× 212 0.9× 22 1.5k
Takashi Nakaoka Japan 22 1.6k 1.5× 341 0.6× 181 0.5× 276 0.9× 221 0.9× 47 2.2k
Sandra W. McLeskey United States 18 1.7k 1.7× 141 0.3× 495 1.3× 418 1.3× 148 0.6× 31 2.3k

Countries citing papers authored by F. vom Dorp

Since Specialization
Citations

This map shows the geographic impact of F. vom Dorp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. vom Dorp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. vom Dorp more than expected).

Fields of papers citing papers by F. vom Dorp

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F. vom Dorp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. vom Dorp. The network helps show where F. vom Dorp may publish in the future.

Co-authorship network of co-authors of F. vom Dorp

This figure shows the co-authorship network connecting the top 25 collaborators of F. vom Dorp. A scholar is included among the top collaborators of F. vom Dorp based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F. vom Dorp. F. vom Dorp is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dorp, F. vom, et al.. (2023). Validation of a 3D‐printed robot‐assisted partial nephrectomy training model. SHILAP Revista de lepidopterología. 5(1). 90–100. 4 indexed citations
2.
Niedworok, Christian, F. vom Dorp, Stephan Tschirdewahn, et al.. (2016). Validation of the diagnostic and prognostic relevance of serum MMP-7 levels in renal cell cancer by using a novel automated fluorescent immunoassay method. International Urology and Nephrology. 48(3). 355–361. 15 indexed citations
3.
Kübler, Hubert, Birgit Scheel, Ulrike Gnad-Vogt, et al.. (2015). Self-adjuvanted mRNA vaccination in advanced prostate cancer patients: a first-in-man phase I/IIa study. Journal for ImmunoTherapy of Cancer. 3(1). 26–26. 211 indexed citations
4.
Niedworok, Christian, F. vom Dorp, Jarowit Piotrowski, et al.. (2014). Renal cell carcinoma and tumour thrombus in the inferior vena cava: clinical outcome of 98 consecutive patients and the prognostic value of preoperative parameters. World Journal of Urology. 33(10). 1541–1552. 16 indexed citations
5.
Niedworok, Christian, et al.. (2014). Nicht muskelinvasives Urothelkarzinom der Harnblase. Der Urologe. 54(2). 235–238. 2 indexed citations
6.
Niedworok, Christian, et al.. (2013). Die gestielte Vorhautlappenplastik. Der Urologe. 52(5). 672–676. 1 indexed citations
7.
Niedworok, Christian, Katharina Röck, Till Freudenberger, et al.. (2013). Inhibitory Role of the Small Leucine-Rich Proteoglycan Biglycan in Bladder Cancer. PLoS ONE. 8(11). e80084–e80084. 39 indexed citations
8.
Dorp, F. vom, Stephan Tschirdewahn, & G. Lümmen. (2012). Instillationstherapie des nichtmuskelinvasiven Harnblasenkarzinoms. Der Urologe. 51(2). 257–264. 1 indexed citations
9.
Szarvas, Tibor, Viktória László, Gero Kramer, et al.. (2012). Circulating Angiostatin, bFGF, and Tie2/TEK Levels and Their Prognostic Impact in Bladder Cancer. Urology. 80(3). 737.e13–737.e18. 10 indexed citations
10.
Szarvas, Tibor, Viktória László, F. vom Dorp, et al.. (2011). Serum endostatin levels correlate with enhanced extracellular matrix degradation and poor patients' prognosis in bladder cancer. International Journal of Cancer. 130(12). 2922–2929. 39 indexed citations
11.
Szarvas, Tibor, Falk Hoffmann, Markus Becker, et al.. (2010). Plasmakonzentrationen von E-Cadherin bei Tumorerkrankungen der Harnblase. Der Urologe. 50(1). 64–70. 4 indexed citations
12.
Dorp, F. vom, et al.. (2010). Inhibition of Rho-Kinase Abrogates Migration of Human Transitional Cell Carcinoma Cells: Results of an in vitro Study. Urologia Internationalis. 86(2). 220–227. 3 indexed citations
13.
Dorp, F. vom, et al.. (2009). The Zeiss-loop stone extraction: minimal invasive and effective or obsolete?. World Journal of Urology. 28(2). 187–192.
14.
Szarvas, Tibor, Tobias Jäger, Martin Tötsch, et al.. (2008). Angiogenic Switch of Angiopietins-Tie2 System and Its Prognostic Value in Bladder Cancer. Clinical Cancer Research. 14(24). 8253–8262. 32 indexed citations
15.
Dorp, F. vom, et al.. (2008). Der Stellenwert der Targeted-Therapie beim Prostatakarzinom. Der Urologe. 47(10). 1315–1319.
16.
Dorp, F. vom, et al.. (2007). Management kutaner Metastasen. Der Urologe. 46(1). 56–58. 3 indexed citations
17.
Szarvas, Tibor, et al.. (2007). Einsatz der Siliziumchiptechnologie zur Detektion von Tumormarkern auf Proteinbasis beim Harnblasenkarzinom. Der Urologe. 46(9). 1152–1156. 6 indexed citations
18.
Dorp, F. vom, et al.. (2007). Palliative Therapiekonzepte bei Patienten mit Urothelkarzinom der Harnblase. Der Urologe. 46(1). 54–55.
19.
Stope, Matthias B., F. vom Dorp, Paschal A. Oude Weernink, et al.. (2004). Epac- and Ca2+-controlled Activation of Ras and Extracellular Signal-regulated Kinases by Gs-coupled Receptors. Journal of Biological Chemistry. 279(45). 46497–46508. 92 indexed citations
20.
Lümmen, G., H. Sperling, A. Eisenhardt, et al.. (2002). Influence of pertussis toxin on superficial bladder carcinoma in rats. Urological Research. 30(3). 199–203. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026